Skip to content

Invest

Month April 2025

Press Releases

Jabez Biosciences, Inc. Announces First Patient Dosed in Phase 1 Oncology Clinical Study of JBZ-001

Shane Hackett
April 3, 2025

Menu

Jabez Biosciences is developing a smarter model for cancer therapy.

Social Media

Jabez Biosciences. 2025. All Rights Reserved.

Site by: Flyte.

Clinical Trials